Two years ago, I told you about how Japan’s Ministry of Health, Labor, and Welfare urged local governments not to promote the HPV vaccine. This about-face occurred as a result of all the adverse effects—like long term pain and numbness—that started cropping up in people who had received the vaccine. (Just in case you’re not familiar with it, human papilloma virus—or HPV—is a common virus that can cause genital warts and cervical cancer.)
Well, now the European Medicines Agency has started its own review of HPV vaccines “to further clarify aspects of their safety profile.” The review was initiated at the request of Denmark, a country that is often on the cutting edge of social issues (and who, by the way, pay some of the highest taxes in the world and yet, still manage to have a higher standard of living than we do here in the US).
Denmark rang the alarm bell for all of Europe after noticing the HPV vaccine seems to be linked to two alarming syndromes
- Complex regional pain syndrome (CRPS)—a condition characterized by chronic pain affecting the limbs
- Postural orthostatic tachycardia syndrome (POTS)—a condition in which the heart rate abnormally increases after sitting or standing up, causing symptoms like dizziness and fainting, as well as headache, chest pain, and weakness.
I’m glad to see the European health authorities taking these reports seriously. But guess what? these adverse reactions have also been reported in the US. Yet the FDA hasn’t made a peep to warn the public. Quite the opposite, in fact.
But these are severe reactions to a vaccine that is given to millions of people—mainly girls and now boys as young as 9 years old—around the world. You need to seriously consider whether it is worth exposing your child, or grandchild to such a vaccine when the outcomes have yet to be proven. This vaccine could very well do more harm than good. Only time will tell. Is that really a risk we want to take with the health of our future generations?
Especially when there’s a much, much safer bet for protecting them from HPV—and any number of other health threats, to boot. Last December, I told you about a new trial showing that one of my favorite natural supplements, AHCC, appears to be effective against HPV. For general immune support, I recommend 1,000 mg of AHCC daily (I typically suggest one 500 mg dose in the morning and one at night).
The JAMA Network Journals. “Life expectancy substantially lower with combination of diabetes, stroke or heart attack.” ScienceDaily. ScienceDaily, 7 July 2015. <www.sciencedaily.com/releases/2015/07/150707115835.htm>.